Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects

Francia, 2010, Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: Systematic review and meta-analysis, Menopause, 17, 660, 10.1097/gme.0b013e3181cb4fb5

Bilal, 2014, Phytoestrogens and prevention of breast cancer: The contentious debate, World J. Clin. Oncol., 5, 705, 10.5306/wjco.v5.i4.705

Wada, 2013, Soy isoflavone intake and breast cancer risk in Japan: From the Takayama study, Int. J. Cancer, 133, 952, 10.1002/ijc.28088

Aguiar, 2007, Analysis of isoflavonoids from leguminous plant extracts by RPHPLC/DAD and electrospray ionization mass spectrometry, Int. J. Food Sci. Nutr., 58, 116, 10.1080/09637480601149350

Vitale, 2013, Isoflavones: Estrogenic activity, biological effect and bioavailability, Eur. J. Drug Metab. Pharmacokinet., 38, 15, 10.1007/s13318-012-0112-y

Kudou, 1991, Malonylisoflavone glycosides in soybean seeds (Glycine max Merrill), Agric. Biol. Chem., 51, 5579

Shinkaruk, 2010, Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity, Nutrients, 2, 340, 10.3390/nu2030340

Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J. Nutr., 131, 1362S, 10.1093/jn/131.4.1362S

Soukup, 2016, Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: A cross-species and sex comparison, Arch. Toxicol., 90, 1335, 10.1007/s00204-016-1663-5

Grace, 2004, Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk, Cancer Epidemiol. Biomark. Prev., 13, 698, 10.1158/1055-9965.698.13.5

Kulling, 2002, Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 777, 211, 10.1016/S1570-0232(02)00215-5

Franke, 2014, Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake, Arch. Biochem. Biophys., 59, 24, 10.1016/j.abb.2014.06.007

Pugazhendhi, 2008, Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells, J. Endocrinol., 197, 503, 10.1677/JOE-07-0384

Guth, 2018, Effects of isoflavones on breast tissue and the thyroid hormone system in humans: A comprehensive safety evaluation, Arch. Toxicol., 92, 2703, 10.1007/s00204-018-2279-8

Bolca, 2010, Disposition of soy isoflavones in normal human breast tissue, Am. J. Clin. Nutr., 91, 976, 10.3945/ajcn.2009.28854

Maubach, 2004, Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids, Obstet. Gynecol., 103, 892, 10.1097/01.AOG.0000124983.66521.6a

Heinonen, 2003, Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton, J. Steroid Biochem. Mol. Biol., 87, 285, 10.1016/j.jsbmb.2003.09.003

Marrian, 1932, Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares’ urine, Biochem. J., 26, 1227, 10.1042/bj0261227

Setchell, 2010, Equol: History, chemistry, and formation, J. Nutr., 140, 1355S, 10.3945/jn.109.119776

Spencer, 2013, Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases, Antiox. Redox Signal., 18, 1818, 10.1089/ars.2012.4581

Schwen, 2012, Elucidation of the metabolic pathway of S-equol in rat, monkey and man, Food Chem. Toxicol., 50, 2074, 10.1016/j.fct.2012.03.048

Kim, 2009, Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Eggerthella strain Julong 732, Appl. Environ. Microbiol., 75, 3062, 10.1128/AEM.02058-08

Setchell, 2005, S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora, Am. J. Clin. Nutr., 81, 1072, 10.1093/ajcn/81.5.1072

Setchell, 2003, Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women, Am. J. Clin. Nutr., 77, 411, 10.1093/ajcn/77.2.411

Jackson, 2011, Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist, Nutr. Rev., 69, 432, 10.1111/j.1753-4887.2011.00400.x

Lund, 2004, Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback, Biol. Reprod., 70, 1188, 10.1095/biolreprod.103.023713

Choi, 2014, The antioxidant activity of daidzein metabolites, O-desmethylangolensin and equol, in HepG2 cells, Mol. Med. Rep., 9, 328, 10.3892/mmr.2013.1752

Wei, 2011, Antioxidant effect of a phytoestrogen equol on cultured muscle cells of embryonic broilers, In Vitro Cell. Dev. Biol. Anim., 47, 735, 10.1007/s11626-011-9464-x

Alfa, H.H., and Arroo, R.R.J. (2019). Over 3 decades of research on dietary flavonoid antioxidants and cancer prevention: What have we achieved?. Phytochem. Rev.

Rafii, 2015, The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol, Metabolites, 5, 56, 10.3390/metabo5010056

Bolca, 2007, Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women, J. Nutr., 137, 2242, 10.1093/jn/137.10.2242

Hall, 2007, Equol producer status, salivary estradiol profile and urinary excretion of isoflavones in Irish Caucasian women, following ingestion of soymilk, Steroids, 72, 64, 10.1016/j.steroids.2006.10.010

Peeters, 2007, Variations in plasma phytoestrogen concentrations in European adults, J. Nutr., 137, 1294, 10.1093/jn/137.5.1294

Setchell, 2006, Method of defining equol-producer status and its frequency among vegetarians, J. Nutr., 136, 2188, 10.1093/jn/136.8.2188

Gardana, 2014, R(-)-O-desmethylangolensin is the main enantiomeric form of daidzein metabolite produced by human in vitro and in vivo, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 953–954, 30, 10.1016/j.jchromb.2014.01.048

Frankenfeld, 2011, O-desmethylangolensin: The importance of equol’s lesser known cousin to human health, Adv. Nutr., 2, 317, 10.3945/an.111.000539

Wiseman, 2004, Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults, Am. J. Clin. Nutr., 80, 692, 10.1093/ajcn/80.3.692

Franke, 2012, Equol production changes over time in postmenopausal women, J. Nutr. Biochem., 23, 573, 10.1016/j.jnutbio.2011.03.002

Akaza, 2004, Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents, Jpn. J. Clin. Oncol., 34, 86, 10.1093/jjco/hyh015

Brown, 2014, S-(-)equol production is developmentally regulated and related to early diet composition, Nutr. Res., 34, 401, 10.1016/j.nutres.2014.03.005

Cao, 2009, Isoflavones in urine, saliva, and blood of infants: Data from a pilot study on the estrogenic activity of soy formula, J. Expo. Sci. Environ. Epidemiol., 19, 223, 10.1038/jes.2008.44

Wada, 2017, Relationship of equol production between children aged 5-7 years and their mothers, Eur. J. Nutr., 56, 1911, 10.1007/s00394-016-1233-x

Frankenfeld, 2004, Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes, Exp. Biol. Med., 229, 902, 10.1177/153537020422900906

Yoshikata, 2019, Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: Baseline findings from a placebo-controlled intervention trial, Menopause, 26, 273, 10.1097/GME.0000000000001202

Clavel, 2005, Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women, J. Nutr., 135, 2786, 10.1093/jn/135.12.2786

Atkinson, 2004, In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production, J. Nutr., 134, 596, 10.1093/jn/134.3.596

Tousen, 2011, Resistant starch promotes equol production and inhibits tibial bone loss in ovariectomized mice treated with daidzein, Metabolism, 60, 1425, 10.1016/j.metabol.2011.02.009

Zheng, 2014, Lactulose promotes equol production and changes the microbial community in vitro of daidzein by fecal inocula of sows, Anaerobe, 25, 47, 10.1016/j.anaerobe.2013.11.011

Decroos, 2005, Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions, Arch. Microbiol., 183, 45, 10.1007/s00203-004-0747-4

Frankenfeld, 2011, Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults, Am. J. Clin. Nutr., 93, 1109, 10.3945/ajcn.111.011825

Decroos, 2006, Administration of equol-producing bacteria alters the equol production status in the Simulator of the Gastrointestinal Microbial Ecosystem (SHIME), J. Nutr., 136, 946, 10.1093/jn/136.4.946

Rosenberg, E., DeLong, E.F., Lory, S., Stackebrandt, E., and Thompson, F. (2014). The family Coriobacteriaceae. The Prokaryotes-Actinobacteria, Springer.

Wang, 2007, Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria, Arch. Microbiol., 187, 155, 10.1007/s00203-006-0183-8

Abiru, 2013, Isolation and characterization of novel S-equol-producing bacteria from brines of stinky tofu, a traditional fermented soy food in Taiwan, Int. J. Food Sci. Nutr., 64, 936, 10.3109/09637486.2013.816936

Matthies, 2009, Isolation of a human intestinal bacterium capable of daidzein and genistein conversion, Appl. Environ. Microbiol., 75, 1740, 10.1128/AEM.01795-08

Matthies, 2012, Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats, J. Nutr., 142, 40, 10.3945/jn.111.148247

Arora, 1998, Antioxidant activities of isoflavones and their biological metabolites in a liposomal system, Arch. Biochem. Biophys., 356, 133, 10.1006/abbi.1998.0783

Ridlon, 2006, Bile salt biotransformations by human intestinal bacteria, J. Lipid Res., 47, 241, 10.1194/jlr.R500013-JLR200

Ramawat, K.G., and Merillon, J.M. (2013). Phenolics in human nutrition: Importance of the intestinal microbiome for isoflavone and lignin bioavailability. Handbook of Natural Products, Springer.

Maruo, 2008, Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella, Int. J. Syst. Evol. Microbiol., 58, 1221, 10.1099/ijs.0.65404-0

Minamida, 2006, Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine, J. Biosci. Bioeng., 102, 247, 10.1263/jbb.102.247

Elghali, 2012, Bioconversion of daidzein to equol by Bifidobacterium breve 15700 and Bifidobacterium longum BB536, J. Funct. Foods, 4, 736, 10.1016/j.jff.2012.04.013

Yu, 2008, Isolation and identification of equol-producing bacterial strains from cultures of pig faeces, FEMS Microbiol. Lett., 282, 73, 10.1111/j.1574-6968.2008.01108.x

Hur, 2000, Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin, Arch. Microbiol., 174, 422, 10.1007/s002030000222

Tamura, 2007, Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces, Anaerobe, 13, 32, 10.1016/j.anaerobe.2006.10.001

Yokoyama, 2008, Isolation and characterization of a novel equol-producing bacterium from human feces, Biosci. Biotechnol. Biochem., 72, 2660, 10.1271/bbb.80329

Wang, 2005, Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium, Appl. Environ. Microbiol., 71, 214, 10.1128/AEM.71.1.214-219.2005

Matthies, 2008, Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine, Appl. Environ. Microbiol., 74, 4847, 10.1128/AEM.00555-08

Kwon, J.E., Lim, J., Kim, I., Kim, D., and Kang, S.C. (2018). Isolation and identification of new bacterial stains producing equol from Pueraria lobata extract fermentation. PLoS ONE, 13.

Heng, Y., Kim, M.J., Yang, H.J., Kang, S., and Park, S. (2019). Lactobacillus intestinalis efficiently produces equol from daidzein and chungkookjang, short-term fermented soybeans. Arch. Microbiol.

Uchiyama, 2007, Identification of a newly isolated equol-producing lactic acid bacterium from the human feces, J. Intest. Microbiol., 21, 217

Guo, 2012, Screening and identification of a bacterium capable of converting daidzein to S-equol, Acta Microbiol. Sin., 52, 696

Jin, 2010, Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol, Int. J. Syst. Evol. Microbiol., 60, 1721, 10.1099/ijs.0.016774-0

Tsuji, 2010, Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS, Arch. Microbiol., 192, 279, 10.1007/s00203-010-0546-z

Shimada, 2010, Cloning and expression of a novel NADP(H)-dependent daidzein reductase, an enzyme involved in the metabolism of daidzein, from equol-producing Lactococcus strain 20-92, Appl. Environ. Microbiol., 76, 5892, 10.1128/AEM.01101-10

Shimada, 2011, Identification of two novel reductases involved in equol biosynthesis in Lactococcus strain 20-92, J. Mol. Microbiol. Biotechnol., 2, 160

Shimada, 2012, Identification of a novel dihydrodaidzein racemase essential for biosynthesis of equol from daidzein in Lactococcus sp. strain 20-92, Appl. Environ. Microbiol., 78, 4902, 10.1128/AEM.00410-12

Toh, 2007, Complete genome sequence of the equol-producing bacterium Adlerkreutzia equolifaciens DSM 19450, Genome Announc., 1, e00742

Yokoyama, 2011, Complete genomic sequence of the equol-producing bacterium Eggerthella sp. strain YY7918, isolated from adult human intestine, J. Bacteriol., 193, 5570, 10.1128/JB.05626-11

Matthies, 2013, Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens, Appl. Environ. Microbiol., 79, 3494, 10.1128/AEM.03693-12

Tsuji, 2012, Identification of an enzyme system for daidzein-to-equol conversion in Slackia sp. strain NATTS, Appl. Environ. Microbiol., 78, 1228, 10.1128/AEM.06779-11

Kawada, 2016, The production of S-equol from daidzein is associated with a cluster or three genes in Eggerthella sp. YY7918, Biosci. Microbiota Food Health, 35, 113, 10.12938/bmfh.2015-023

Flórez, A.B., Vázquez, L., Rodríguez, J., Redruello, B., and Mayo, B. (2019). Transcriptional regulation of the equol biosynthesis gene cluster in Adlercreutzia equolifaciens DSM19450T. Nutrients, 11.

Lee, 2017, Biosynthesis of (-)-5-hydroxy-equol and 5-hydroxy-dehydroequol from soy isoflavone, genistein using microbial whole cell bioconversion, ACS Chem. Biol., 12, 2883, 10.1021/acschembio.7b00624

Li, 2018, To construct an engineered (S)-equol resistant E. coli for in vitro (S)-equol production, Front. Microbiol., 9, 1182, 10.3389/fmicb.2018.01182

Lee, 2016, P212A mutant of dihydrodaidzein reductase enhances (S)-equol production and enantioselectivity in a recombinant Escherichia coli whole-cell reaction system, Appl. Environ. Microbiol., 82, 1992, 10.1128/AEM.03584-15

Lee, 2018, Polymeric solvent engineering for gram/liter scale production of a water-insoluble isoflavone derivative, (S)-equol, Appl. Microbiol. Biotechnol., 102, 6915, 10.1007/s00253-018-9137-8

Murota, 2018, Flavonoid metabolism: The interaction of metabolites and gut microbiota, Biosci. Biotechnol. Biochem., 82, 600, 10.1080/09168451.2018.1444467

Selma, 2016, Interactions of gut microbiota with dietary polyphenols and consequences to human health, Curr. Opin. Clin. Nutr. Metab. Care, 19, 471, 10.1097/MCO.0000000000000314

Braune, 2018, Evaluation of inter-individual differences in gut bacterial isoflavone bioactivation in humans by PCR-based targeting of genes involved in equol formation, J. Appl. Microbiol., 124, 220, 10.1111/jam.13616

Guadamuro, 2017, Development and use of a real-time quantitative PCR method for detecting and quantifying equol-producing bacteria in human faecal samples and slurry cultures, Front. Microbiol., 8, 1155, 10.3389/fmicb.2017.01155

Cho, 2016, Quantification of Slackia and Eggerthella sp. in human feces and adhesion of representatives strains to Caco-2 Cells, Front. Microbiol., 7, 658, 10.3389/fmicb.2016.00658

Sugiyama, 2014, Counts of Slackia sp. strain NATTS in intestinal flora are correlated to serum concentrations of equol both in prostate cancer cases and controls in Japanese men, Asian Pac. J. Cancer Prev., 15, 2693, 10.7314/APJCP.2014.15.6.2693

Harmsen, 2000, Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups, Appl. Environ. Microbiol., 66, 4523, 10.1128/AEM.66.10.4523-4527.2000

Stewart, B.W., and Wild, C.P. (2014). The global and regional burden of cancer. World Cancer Report 2014, International Agency for Research on Cancer (IARC).

Liu, 2014, Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women, Menopause, 21, 653, 10.1097/GME.0000000000000102

He, 2013, Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms, Food Sci. Hum. Wellness, 2, 146, 10.1016/j.fshw.2013.08.002

Yamori, 2006, Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers, Exp. Clin. Cardiol., 11, 94

Mulligan, 2013, Intakes and sources of isoflavones, lignans, enterolignans, coumestrol and soya-containing foods in the Norfolk arm of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk), from 7 d food diaries, using a newly updated database, Public Health Nutr., 16, 1454, 10.1017/S1368980012003904

Knaze, 2012, Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort, Eur. J. Clin. Nutr., 66, 932, 10.1038/ejcn.2012.36

Messina, 2006, Estimated Asian adult soy protein and isoflavone intakes, Nutr. Cancer, 55, 1, 10.1207/s15327914nc5501_1

Jayachandran, 2019, An insight into the health benefits of fermented soy products, Food Chem., 271, 362, 10.1016/j.foodchem.2018.07.158

Zhou, 2015, Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis, Clin. Nutr., 35, 117

Wei, 2012, Systematic review of soy isoflavone supplements on osteoporosis in women, Asian Pac. J. Trop. Med., 5, 243, 10.1016/S1995-7645(12)60033-9

Harland, 2008, Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol, Atherosclerosis, 200, 13, 10.1016/j.atherosclerosis.2008.04.006

EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food) (2015). Scientific opinion on the risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA J., 13, 4246.

Hazim, 2016, Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: A double-blind randomized controlled trial, Am. J. Clin. Nutr., 103, 694, 10.3945/ajcn.115.125690

Acharjee, 2015, Effects of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status, Metabolism, 64, 236, 10.1016/j.metabol.2014.09.005

Wong, 2012, Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods, Am. J. Clin. Nutr., 95, 564, 10.3945/ajcn.111.017418

Thorp, 2008, Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers, Am. J. Clin. Nutr., 88, 298, 10.1093/ajcn/88.2.298

Jou, 2008, Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones, Int. J. Gynecol. Obstet., 102, 44, 10.1016/j.ijgo.2008.01.028

Akhlaghi, 2017, Effect of soy and soy isoflavones on obesity-related anthropometric measures: A systematic review and meta-analysis of randomized controlled clinical trials, Adv. Nutr., 8, 705, 10.3945/an.117.015370

Fang, 2016, Soy isoflavones and glucose metabolism in menopausal women: A systematic review and meta-analysis of randomized controlled trials, Mol. Nutr. Food Res., 60, 1602, 10.1002/mnfr.201501024

Cheng, 2015, Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis, Menopause, 22, 198, 10.1097/GME.0000000000000290

Bone, 2014, Soy and soy isoflavones in prostate cancer: A systematic review and meta-analysis of randomized controlled trials, BJU Int., 113, E119

Lethavy, A., Marjoribanks, J., Kronenberg, F., Roberts, H., Eden, J., and Brown, J. (2013). Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst. Rev., 12.

Taku, 2010, Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials, Bone, 47, 413, 10.1016/j.bone.2010.05.001

EFSA DNS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food) (2012). Scientific Opinion on the substantiation of health claims related to soy isoflavones and maintenance of bone mineral density (ID 1655) and reduction of vasomotor symptoms associated with menopause (ID 1654, 1704, 2140, 3093, 3154, 3590) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 10, 2847.

Iwasaki, 2010, Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians, Nutr. Cancer, 62, 466, 10.1080/01635580903441279

Low, 2006, Implications of gene-environment interaction in studies of gene variants in breast cancer: An example of dietary isoflavones and the D356N polymorphism in the sex hormone-binding globulin gene, Cancer Res., 66, 8980, 10.1158/0008-5472.CAN-06-2432

Guadamuro, 2015, Equol status and changes in faecal microbiota in menopausal women receiving long-term treatment for menopause symptoms with a soy-isoflavone concentrate, Front. Microbiol., 6, 777, 10.3389/fmicb.2015.00777

Nakatsu, C.H., Armstrong, A., Cavijo, A.P., Martin, B.R., Barnes, S., and Weaver, C.M. (2014). Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS ONE, 9.

Ahuja, 2017, Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men, Br. J. Nutr., 117, 260, 10.1017/S000711451600458X

Wu, 2007, Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: A double-blind, randomized, controlled trial, Menopause, 14, 866, 10.1097/gme.0b013e3180305299

Newton, 2015, A cross-sectional study of equol producer status and self-reported vasomotor symptoms, Menopause, 22, 489, 10.1097/GME.0000000000000363

Nettleton, 2005, The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption, J. Nutr., 135, 603, 10.1093/jn/135.3.603

Hidayat, 2015, Effect of soy isoflavone supplementation on endothelial dysfunction and oxidative stress in equol-producing postmenopausal women, Endocr. Metab. Immune Disord. Drug Targets, 15, 71, 10.2174/1871530314666141202123309

Geelen, 2014, Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: A double-blind, randomized, placebo-controlled crossover trial in postmenopausal women, Am. J. Clin. Nutr., 100, 1269, 10.3945/ajcn.114.088484

Crawford, 2013, Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: A pilot randomized trial, Menopause, 20, 936

Pawlowski, 2015, Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: A randomized crossover trial, Am. J. Clin. Nutr., 102, 695, 10.3945/ajcn.114.093906

Thomas, 2006, Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: A potential novel mechanism of endocrine disruption, J. Steroid Biochem. Mol. Biol., 102, 175, 10.1016/j.jsbmb.2006.09.017

2012, The presence of monoiodinated derivates of daidzein and genistein in human urine and its effect on thyroid gland function, Food Chem. Toxicol., 50, 2774, 10.1016/j.fct.2012.05.037

Dharmawardhane, 2012, The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G, J. Biol. Chem., 287, 41640, 10.1074/jbc.M112.393470

Messina, M. (2016). Soy and health update: Evaluation of the clinical and epidemiologic literature. Nutrients, 8.

Hermenegildo, 2005, Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells, J. Pharmacol. Exp. Ther., 315, 722, 10.1124/jpet.105.090456

Steffensen, 2012, Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice, Diabetologia, 55, 2469, 10.1007/s00125-012-2599-9

Reynolds, 2006, A meta-analysis of the effect of soy protein supplementation on serum lipids, Am. J. Cardiol., 98, 633, 10.1016/j.amjcard.2006.03.042

Rosell, 2004, Soy intake and blood cholesterol concentrations: A cross-sectional study of 1033 pre- and postmenopausal women in the Oxford arm of the European Prospective Investigation into Cancer and Nutrition, Am. J. Clin. Nutr., 80, 1391, 10.1093/ajcn/80.5.1391

Aso, 2012, A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women, J. Women’s Health, 21, 92, 10.1089/jwh.2011.2753

Tousen, 2011, Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: A pilot randomized, placebo-controlled trial, Menopause, 18, 563, 10.1097/gme.0b013e3181f85aa7

Ishiwata, 2009, New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women, Menopause, 16, 141, 10.1097/gme.0b013e31818379fa

Jenks, 2012, A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency, J. Women’s Health, 21, 674, 10.1089/jwh.2011.3153

Yoshikata, 2018, Effects of equol supplement on bone and cardiovascular parameters in middle-aged Japanese women: A prospective observational study, J. Altern. Complement. Med., 24, 701, 10.1089/acm.2018.0050

Daily, 2019, Equol decreases hot flashes in postmenopausal women: A systematic review and meta-analysis of randomized clinical trials, J. Med. Food, 22, 127, 10.1089/jmf.2018.4265

Sekikawa, 2019, Effect of S-equol and soy isoflavones on heart and brain, Curr. Cardiol. Rev., 15, 114, 10.2174/1573403X15666181205104717

Usui, 2012, Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status, Clin. Endocrinol., 78, 365, 10.1111/j.1365-2265.2012.04400.x

Tai, 2012, The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: A 2-year randomized double-blind placebo-controlled study, Osteoporos. Int., 23, 1571, 10.1007/s00198-011-1750-7

Cassidy, 2006, Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women, Proc. Nutr. Soc., 65, 76, 10.1079/PNS2005476

Arjmandi, 2002, Soy isoflavones osteoprotective role in postmenopausal women: Mechanisms of action, J. Nutr. Biochem., 13, 130, 10.1016/S0955-2863(02)00172-9

Lin, 2016, Equol suppresses inflammatory response and bone erosion due to rheumatoid arthritis in mice, J. Nutr. Biochem., 32, 101, 10.1016/j.jnutbio.2016.02.012

Mahmoud, 2014, Soy isoflavones and prostate cancer: A review of molecular mechanisms, J. Steroid Biochem. Mol. Biol., 140, 116, 10.1016/j.jsbmb.2013.12.010

Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., and Sagar, S. (2013). Soy, red clover, and isoflavones and breast cancer: A systematic review. PLoS ONE, 8.

Messina, 2017, Health impact of childhood and adolescent soy consumption, Nutr. Rev., 75, 500, 10.1093/nutrit/nux016

Wu, 2004, Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County, Carcinogenesis, 25, 77, 10.1093/carcin/bgg189

Verheus, 2007, Plasma phytoestrogens and subsequent breast cancer risk, J. Clin. Oncol., 25, 648, 10.1200/JCO.2006.06.0244

Ward, 2008, Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study, Breast Cancer Res., 10, R32, 10.1186/bcr1995

Fuhrman, 2008, Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women, Cancer Epidemiol. Biomarkers Prev., 17, 33, 10.1158/1055-9965.EPI-07-0193

Liu, 2003, Prevalence of dementia in China, Dement. Geriatr. Cogn. Disor., 15, 226, 10.1159/000068784

Sarkaki, 2008, Pre-treatment effect of different doses of soy isoflavones on spatial learning and memory in an ovariectomized animal model of Alzheimer’s disease, Pak. J. Biol. Sci., 11, 1114, 10.3923/pjbs.2008.1114.1119

Fournier, 2007, The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women, J. Nutr. Health Aging, 11, 155

Karvaj, 2007, Positive effect of flavonoids to cardiovascular and central nervous system, Neuro Endocrinol. Lett., 28, 1

Kok, 2007, Dietary phytoestrogen intake and cognitive function in older women, J. Gerontol. A Biol. Sci. Med. Sci., 62, 556, 10.1093/gerona/62.5.556

Duffy, 2003, Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones, Pharmacol. Biochem. Behav., 75, 721, 10.1016/S0091-3057(03)00116-3

Soni, 2014, Phytoestrogens and cognitive function: A review, Maturitas, 77, 209, 10.1016/j.maturitas.2013.12.010

Oyama, 2012, The effects of natural S-equol supplementation on skin aging in postmenopausal women: A pilot randomized placebo-controlled trial, Menopause, 19, 202, 10.1097/gme.0b013e318227427b

Magnet, 2017, Topical equol preparation improves structural and molecular skin parameters, Int. J. Cosmet. Sci., 39, 535, 10.1111/ics.12408

Charles, 2009, Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women, Menopause, 16, 395, 10.1097/gme.0b013e3181857979

Gardana, 2017, Long-term kinetics of daidzein and its main metabolites in human equol-producers after soymilk intake: Identification of equol-conjugates by UPLC-orbitrap-MS and influence of the number of transforming bacteria on plasma kinetics, Int. J. Food Sci. Nutr., 68, 496, 10.1080/09637486.2016.1256380

Chadha, 2017, Dietary soy isoflavone: A mechanistic insight, Nat. Prod. Commun., 12, 627

Paterni, 2014, Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential, Steroids, 90, 13, 10.1016/j.steroids.2014.06.012

Lehmann, 2005, Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells, Toxicol. Lett., 158, 72, 10.1016/j.toxlet.2005.02.011

Hertrampf, 2005, Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens, Mol. Cell. Endocrinol., 243, 51, 10.1016/j.mce.2005.08.007

Yang, 2016, Equol induces mitochondria-dependent apoptosis in human gastric cancer cells via the sustained activation of ERK1/2 pathway, Mol. Cells, 39, 742, 10.14348/molcells.2016.0162

Shinkaruk, 2013, Bioavailability of glycitein relatively to other soy isoflavones in healthy young Caucasian men, Food Chem., 135, 1104, 10.1016/j.foodchem.2012.03.135

Rietjens, 2013, Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks, Mol. Nutr. Food Res., 57, 100, 10.1002/mnfr.201200439

Joy, 2006, The isoflavone equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells, J. Biol. Chem., 281, 27335, 10.1074/jbc.M602803200

Rowlands, 2011, Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: Roles for F-actin and GPR30, Hypertension, 57, 833, 10.1161/HYPERTENSIONAHA.110.162198

Kamiyama, 2009, Effects of equol on oxidized low-density lipoprotein-induced apoptosis in endothelial cells, J. Atheroscler. Thromb., 16, 239, 10.5551/jat.1057

Gou, 2015, Equol inhibits LPS-induced oxidative stress and enhances the immune response in chicken HD11 macrophages, Cell. Physiol. Biochem., 36, 611, 10.1159/000430124

Zhang, T., Hu, Q., Shi, L., Qin, L., Zhang, Q., and Mi, M. (2016). Equol attenuates atherosclerosis in apolipoprotein E-deficient mice by inhibiting endoplasmic reticulum stress via activation of Nrf2 in endothelial cells. PLoS ONE, 11.

Casagrande, 2001, Effect of structurally related flavonoids on cell cycle progression of human melanoma cells: Regulation of cyclin-dependent kinases CDK11 and CDK2, Biochem. Pharmacol., 61, 1205, 10.1016/S0006-2952(01)00583-4

Mizushina, 2013, Inhibitory effect of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation, Int. J. Oncol., 43, 1117, 10.3892/ijo.2013.2032

Ono, 2017, Equol enhances apoptosis-inducing activity of genistein by increasing Bax/Bcl-xL expression ratio in MCF-7 human breast cancer cells, Nutr. Cancer, 69, 1300, 10.1080/01635581.2017.1367945

Kim, 2014, Equol induces mitochondria-mediated apoptosis of human cervical cancer cells, Anticancer Res., 34, 4985

Itsumi, 2016, Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2, Cancer Sci., 107, 1022, 10.1111/cas.12948

Lu, 2016, S-equol, a secondary metabolite of natural anticancer isoflavone daidzein, inhibits prostate cancer growth in vitro and in vivo, though activating the Akt/FOXO3a pathway, Curr. Cancer Drug Targets, 16, 455, 10.2174/1568009616666151207105720

Yang, 2015, Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway, World J. Gastroenterol., 21, 10385, 10.3748/wjg.v21.i36.10385

Harada, 2018, Bacterial metabolite S-equol modulates glucagon-like peptide-1 secretion from enteroendocrine L cell line GLUTag cells via actin polymerization, Biochem. Biophys. Res. Commun., 501, 1009, 10.1016/j.bbrc.2018.05.100

Andersen, 2018, Glucagon-like peptide 1 in health and disease, Nat. Rev. Endocrinol., 14, 390, 10.1038/s41574-018-0016-2

Horiuchi, 2017, S-Equol activates cAMP signaling at the plasma membrane of INS-1 pancreatic β-cells and protects against streptozotocin-induced hyperglycemia by increasing β-cell function in male mice, J. Nutr., 147, 1631, 10.3945/jn.117.250860

Gopaul, 2012, Biochemical investigation and gene analysis of equol: A plant and soy-derived isoflavonoid with antiaging and antioxidant properties with potential human skin applications, Biofactors, 38, 44, 10.1002/biof.191